The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The industry that negotiates drug prices for employers has worked to stay ahead of the game.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...

Negotiations Will Occur in 2026 With Negotiated Prices Effective in 2028.8, 2026 - On Tuesday, the Centers for Medicare & ...

Despite pledges to lower drug costs through Trump-backed pricing deals and direct-to-patient programs, pharmaceutical companies entered 2026 by raising list prices on hundreds of brand-name medicines, ...

RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on prescription drugs will work ...

The prices of hundreds of prescription medications in the United States are expected to climb in 2026, according to a new industry analysis, raising questions about the effectiveness of recent Trump ...